A Novel Loss-of-Function Variant in COL4A3 in a Consanguineous Moroccan Family Displaying the Alport Syndrome with Variable Clinical Expression

被引:0
作者
Taroua, Oumayma [1 ]
Askander, Omar [2 ]
Rhou, Hakima [1 ]
Bouhouche, Ahmed [3 ,4 ]
机构
[1] Cheikh Zaid Int Univ Hosp, Nephrol Dept, Rabat, Morocco
[2] Mohammed VI Univ Polytech, Fac Med Sci, Ben Guerir, Morocco
[3] Mohammed V Univ, Med Sch & Pharm, Lab Human Genet, Rabat, Morocco
[4] Abulcasis Int Univ Hlth Sci, Genom Ctr Cheikh Zaid Fdn, Rabat, Morocco
关键词
Alport syndrome; Whole exome sequencing; Novel nonsense variant; Pseudodominance; DIGENIC INHERITANCE; MUTATIONS; GENES; DISEASE;
D O I
10.1159/000540122
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Alport syndrome (AS) is a rare genetic disorder characterized by abnormalities in the kidneys, ears, and eyes. Its clinical presentation typically manifests in childhood or adolescence and varies widely among affected individuals, ranging from isolated hematuria to end-stage renal disease. The genetic causes of AS primarily involve mutations in the genes encoding type IV collagen COL4A3, COL4A4, and COL4A5, which play essential roles in maintaining the structural integrity of the glomerular basement membrane in the kidney, the cochlea, and the retina. They can be transmitted in autosomal dominant, autosomal recessive, and X-linked recessive. Case Presentation: Here we report a Moroccan consanguineous family with an 18-year-old girl who presented with advanced renal failure and microscopic hematuria. Her audiometry revealed hearing impairment. Urinalysis performed in all the asymptomatic family members showed microscopic hematuria in the mother and younger sister, while computed tomography excluded a urologic cause. Using next-generation sequencing analysis, we identified in the proband a nonsense homozygous variant in the COL4A3 gene (c.4114C>T, p.Gln1372Ter) that was never reported in the literature, and which is considered pathogenic according to the ACMG classification. Segregation analysis in the family showed that the parents were heterozygous like the elder brother, whereas the younger sister was mutated homozygous, and the other brother was homozygous normal. Conclusion: We report a novel nonsense pathogenic variant in COL4A3 that expends the allelic spectrum in AS. Clinical exploration and genetic testing of all the family members revealed intrafamilial clinical variability, suggesting a pseudo-dominant inheritance and a reduced penetrance.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 24 条
  • [1] Alport Syndrome: A Comprehensive Review
    Adone, Avanti
    Anjankar, Ashish
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [2] Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248
  • [3] Alport Syndrome: Clinical Spectrum and Therapeutic Advances
    De Gregorio, Vanessa
    Caparali, Emine Bilge
    Shojaei, Azadeh
    Ricardo, Samantha
    Barua, Moumita
    [J]. KIDNEY MEDICINE, 2023, 5 (05)
  • [4] Alport syndrome: impact of digenic inheritance in patients management
    Fallerini, C.
    Baldassarri, M.
    Trevisson, E.
    Morbidoni, V.
    La Manna, A.
    Lazzarin, R.
    Pasini, A.
    Barbano, G.
    Pinciaroli, A. R.
    Garosi, G.
    Frullanti, E.
    Pinto, A. M.
    Mencarelli, M. A.
    Mari, F.
    Renieri, A.
    Ariani, F.
    [J]. CLINICAL GENETICS, 2017, 92 (01) : 34 - 44
  • [5] GENETIC-HETEROGENEITY OF ALPORT SYNDROME
    FEINGOLD, J
    BOIS, E
    CHOMPRET, A
    BROYER, M
    GUBLER, MC
    GRUNFELD, JP
    [J]. KIDNEY INTERNATIONAL, 1985, 27 (04) : 672 - 677
  • [6] Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study
    Furlano, Monica
    Martinez, Victor
    Pybus, Marc
    Arce, Yolanda
    Crespi, Jaume
    Venegas, Maria del Prado
    Bullich, Gemma
    Domingo, Andrea
    Ayasreh, Nadia
    Benito, Silvia
    Lorente, Laura
    Ruiz, Patricia
    Gonzalez, Vanesa Lopez
    Arlandis, Rosa
    Cabello, Elisa
    Torres, Ferran
    Guirado, Lluis
    Ars, Elisabet
    Torra, Roser
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (04) : 560 - U82
  • [7] Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome
    Gibson, Joel
    Fieldhouse, Rachel
    Chan, Melanie M. Y.
    Sadeghi-Alavijeh, Omid
    Burnett, Leslie
    Izzi, Valerio
    Persikov, Anton V.
    Gale, Daniel P.
    Storey, Helen
    Savige, Judy
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (09): : 2273 - 2290
  • [8] AUTOSOMAL RECESSIVE ALPORT SYNDROME - IMMUNOHISTOCHEMICAL STUDY OF TYPE-IV COLLAGEN CHAIN DISTRIBUTION
    GUBLER, MC
    KNEBELMANN, B
    BEZIAU, A
    BROYER, M
    PIRSON, Y
    HADDOUM, F
    KLEPPEL, MM
    ANTIGNAC, C
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (04) : 1142 - 1147
  • [9] Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4)
    Jefferson, JA
    Lemmink, HH
    Hughes, AE
    Hill, CM
    Smeets, HJM
    Doherty, CC
    Maxwell, AP
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (08) : 1595 - 1599
  • [10] Kashtan CE, 2021, PEDIATR NEPHROL, V36, P711, DOI 10.1007/s00467-020-04819-6